Ilse Molendijk
Impact in
Papers in
- Co-authors
- Andrea E. van der Meulen‐de Jong (12 shared papers)Hein W. Verspaget (11 shared papers)C. Janneke van der Woude (3 shared papers)Daniël W. Hommes (7 shared papers)Willem E. Fibbe (4 shared papers)Helene Roelofs (4 shared papers)Marjolijn Duijvestein (4 shared papers)Veerle J. Nuij (1 shared paper)
- Journals
- Journal of Crohn s and Colitis (4 papers)Inflammatory Bowel Diseases (2 papers)Stem Cells (1 paper)Journal of Cellular and Molecular Medicine (1 paper)Immunity (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
Ilse Molendijk
17 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Genetics 440
- Surgery 518
- Genetics 318
- Immunology 192
- Oncology 215
Countries citing papers authored by Ilse Molendijk
This map shows the geographic impact of Ilse Molendijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Molendijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Molendijk more than expected).
Fields of papers citing papers by Ilse Molendijk
This network shows the impact of papers produced by Ilse Molendijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Molendijk. The network helps show where Ilse Molendijk may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilse Molendijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 283 | |
| 2 | 2015 | 252 | |
| 3 | 2014 | 118 | |
| 4 | 2016 | 100 | |
| 5 | 2019 | 99 | |
| 6 | 2011 | 40 | |
| 7 | 2019 | 27 | |
| 8 | 2016 | 22 | |
| 9 | 2019 | 19 | |
| 10 | 2018 | 18 | |
| 11 | 2012 | 14 | |
| 12 | 2018 | 12 | |
| 13 | 2018 | 12 | |
| 14 | 2021 | 9 | |
| 15 | 2014 | 8 | |
| 16 | 2019 | 4 | |
| 17 | [Important rise in antibiotic resistance rates inHelicobacter pyloriin the Netherlands]. | 2022 | 1 |
About Ilse Molendijk
Ilse Molendijk is a scholar working on Surgery, Genetics, Genetics, Oncology and Epidemiology, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Mesenchymal stem cell research (5 papers), Anorectal Disease Treatments and Outcomes (5 papers), Cancer Cells and Metastasis (4 papers), Stoma care and complications (3 papers), Diverticular Disease and Complications (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). The work is most often cited by research in Genetics (440 citations), Surgery (518 citations), Genetics (318 citations), Immunology (192 citations) and Oncology (215 citations). Ilse Molendijk has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Andrea E. van der Meulen‐de Jong, Hein W. Verspaget, C. Janneke van der Woude, Daniël W. Hommes, Willem E. Fibbe, Helene Roelofs, Marjolijn Duijvestein, Veerle J. Nuij, Koen Peeters and Bert A. Bonsing. Their work appears in journals such as Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, Stem Cells, Journal of Cellular and Molecular Medicine and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.